Cosmos Health Inc. (NASDAQ:COSM) CEO Buys $198,405.76 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas bought 354,296 shares of the business’s stock in a transaction dated Monday, February 24th. The shares were acquired at an average cost of $0.56 per share, for a total transaction of $198,405.76. Following the purchase, the chief executive officer now owns 3,897,016 shares of the company’s stock, valued at approximately $2,182,328.96. The trade was a 10.00 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.66 per share, for a total transaction of $33,933.24.
• On Wednesday, January 22nd, Grigorios Siokas bought 38,900 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.77 per share, for a total transaction of $29,953.00.
• On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.86 per share, for a total transaction of $25,075.88.
• On Wednesday, January 15th, Grigorios Siokas bought 62,500 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.80 per share, for a total transaction of $50,000.00.
• On Monday, January 13th, Grigorios Siokas bought 163,666 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.61 per share, for a total transaction of $99,836.26.
• On Friday, December 20th, Grigorios Siokas bought 257,334 shares of Cosmos Health stock. The shares were acquired at an average cost of $0.58 per share, for a total transaction of $149,253.72.

Cosmos Health Stock Down 4.2 %

Shares of NASDAQ:COSM opened at $0.57 on Thursday. The business’s 50 day moving average is $0.69 and its 200 day moving average is $0.81. The stock has a market cap of $13.14 million, a P/E ratio of -0.23 and a beta of 5.56. Cosmos Health Inc. has a 52-week low of $0.47 and a 52-week high of $1.58. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC boosted its position in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the quarter. Geode Capital Management LLC owned about 0.83% of Cosmos Health worth $129,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 12.61% of the company’s stock.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.